[Vaccination against human papillomavirus infections]

Related Experiment Video

Updated: Jul 17, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Jean-Luc Prétet1, Eva Alvarez, Sylvain Monnier-Benoit

  • 1*EA3181, IFR 133, université de Franche-Comté, laboratoire de biologie cellulaire et moléculaire, CHU Jean-Minjoz, 25030 Besançon. jean_luc.pretet@univ-fcomte.fr

La Revue Du Praticien
|January 25, 2007
PubMed

Insights

Prophylactic vaccines against human papillomaviruses (HPV) show significant cervical lesion reduction in clinical trials. Further research is needed to optimize HPV vaccination strategies and global implementation.

Area of Science:

  • Oncology
  • Immunology
  • Virology

Context:

  • Human papillomaviruses (HPV) are linked to benign lesions and cancers.
  • Two main vaccine strategies exist: therapeutic and prophylactic.
  • Therapeutic vaccines aim to eliminate infected cells, while prophylactic vaccines prevent infection.

Purpose:

  • To evaluate the efficacy of HPV vaccination strategies.
  • To compare therapeutic and prophylactic vaccine approaches.
  • To identify challenges in implementing HPV vaccination globally.

Summary:

  • Prophylactic HPV vaccines have demonstrated significant benefits, with no high-grade cervical lesions observed in vaccinated individuals in clinical trials.
  • Therapeutic vaccine strategies show promise in animal models but require further human efficacy studies.
  • Key questions remain regarding optimal vaccination age, target populations, booster requirements, and accessibility in developing countries.

Impact:

  • Prophylactic HPV vaccination offers a promising strategy for preventing HPV-associated cancers.
  • Addressing implementation challenges is crucial for maximizing the public health impact of HPV vaccines.
  • Further research will refine vaccination protocols and ensure equitable access worldwide.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...